ALS offers formulation development services to help clients determine optimal dosage levels of therapeutic formulations.
ALS has a strong R&D department equipped with modern facilities to deliver the services those include pre – formulation, formulation development, method development, method validation, and analytical development and stability studies.
Our formulation development solutions focus on generic formulations fulfilling regulatory requirements of target markets to achieve quality attributes and performance metrics set by clients. We provide end to end solutions from pre-formulation to manufacturing.
- Our strong scientific team has a broad expertise in collaborative practices with a global customer base for formulation development services and analytical support.
- Our dedicated DQA team closely works with the R&D, Regulatory and Plant QA to ensure that a culture of quality is inherent in the entire product development process.
- We have our In house regulatory expert having experience of both regulated and emerging markets, thus providing an end to end service.
Our expertise is development of :
1. Oral liquids and solid dosage forms :
2. Injectable formulations:
Terminal (Under Plan)
3. Semisolids and Pour-ons